Podium and Symposium Sessions

Type here to filter the list

Saturday, February 15, 2020
7:30 AM – 9:30 AM

HPB Session 1

7:30 AM – 7:45 AM

HPB1 - A Phase II Trial of Hepatic Artery Infusional Floxuridine With Systemic Chemotherapy in the Treatment of Pancreatic Cancer Liver Metastases
Location: Sebastian I 1/2

TrackHPB

Favorite

G. Paul Wright, MD – Spectrum Health/Michigan State University ### 915803###Oral Abstract Presenter

7:45 AM – 8:00 AM

HPB2 - Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent HAI and Systemic Chemotherapy for Colorectal Liver Metastases
Location: Sebastian I 1/2

TrackHPB

Favorite

John M. Creasy, MD – Duke University Medical Center ### 915759###Oral Abstract Presenter

8:00 AM – 8:15 AM

HPB3 - Role of Intraoperative Margin Treatment for Resection of Colorectal Liver Metastases
Location: Sebastian I 1/2

TrackHPB

Favorite

Tracey Pu, BS – Wake Forest School of Medicine ### 915786###Oral Abstract Presenter

8:15 AM – 8:30 AM

HPB4 - Safety and Efficacy of Peptide Receptor Radionucleotide Therapy (PRRT) in Metastatic Neuroendocrine Tumors: A US Single-Institution Experience Post-FDA Approval
Location: Sebastian I 1/2

TrackHPB

Favorite

Erin A. Strong, MD, MBA – Medical College of Wisconsin ### 915798###Oral Abstract Presenter

8:30 AM – 9:30 AM

Metastatic Neuroendocrine Tumor Confined to the Liver
Location: Sebastian I 1/2

TrackHPB

Favorite

Sepideh Gholami, MD – University of California Davis Health ### 915764###Moderator @@@ Alexandra Gangi, MD – Cedars Sinai Medical Center ### 915762###Moderator

8:30 AM – 9:30 AM

Metastatic Neuroendocrine Tumor Confined to the Liver

8:30 AM – 8:45 AM

Medical Oncology
Location: Sebastian I 1/2

TrackHPB

Favorite

Daniel M. Halperin, MD – University of Texas MD Anderson Cancer Center ### 917901###Speaker

8:45 AM – 9:00 AM

Interventional Radiology (Embolization)
Location: Sebastian I 1/2

TrackHPB

Favorite

Riad Salem, MD – Northwestern University ### 917912###Speaker

9:00 AM – 9:15 AM

Surgery
Location: Sebastian I 1/2

TrackHPB

Favorite

James R. Howe, MD – University of Iowa ### 917903###Speaker

9:15 AM – 9:30 AM

Two cases with panel discussion
Location: Sebastian I 1/2

TrackHPB

Favorite

Alexandra Gangi, MD – Cedars Sinai Medical Center ### 915762###Moderator @@@ Sepideh Gholami, MD – University of California Davis Health ### 915764###Moderator

10:00 AM – 11:30 AM

Peritoneal Metastases Session 1

10:00 AM – 10:15 AM

PM1 - Impact of Socioeconomic Status on Outcomes in Colorectal Cancer with Peritoneal Metastases
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Caroline Rieser, MD – University of Pittsburgh Medical Center ### 915790###Oral Abstract Presenter

10:15 AM – 10:30 AM

PM2 - The Hidden Length of Stay following Cytoreductive Surgery/HIPEC: Risk Factors for Unplanned 90-Day Readmission
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Robert J. Torphy, MD – University of Colorado ### 915800###Oral Abstract Presenter

10:30 AM – 10:45 AM

PM3 - Travel Distance and the Impact on Post-Surgical Outcomes and Overall Survival after CRS/HIPEC. A Study from the US HIPEC Collaborative
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Bernardo M. Pessoa, MD – Johns Hopkins University ### 926139###Oral Abstract Presenter

10:45 AM – 11:00 AM

PM4 - Impact of Enhanced Recovery after Surgery Program on Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

George Salti, MD – Edward-Elmhurst Health ### 915791###Oral Abstract Presenter

11:00 AM – 11:15 AM

PM5 - Defining ‘Complete Cytoreduction’ after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) for the Histopathologic Spectrum of Appendiceal Carcinomatosis
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Carlos A. Munoz-Zuluaga, MD – Mercy Medical Center ### 915781###Oral Abstract Presenter

11:15 AM – 11:30 AM

PM6 - What Drives High Cytoreductive Surgery and HIPEC Costs: Patient, Provider or Tumor?
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Patrick B. Schwartz, MD – University of Wisconsin School of Medicine and Public Health ### 915793###Oral Abstract Presenter

1:30 PM – 3:00 PM

Peritoneal Metastases Session 2

1:30 PM – 1:45 PM

PM7 - Colon Cancer with Peritoneal Metastasis: a National Cancer Database Analysis of Treatment Sequencing Trends
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Braden Jensen, MD – University of Iowa ### 915769###Oral Abstract Presenter

1:45 PM – 2:00 PM

PM8 - Failure to Thrive Following CRS-HIPEC: Causes and Consequences
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Caroline Rieser, MD – University of Pittsburgh Medical Center ### 915790###Oral Abstract Presenter

2:00 PM – 2:15 PM

PM9 - Surgical Phenotype of Patients with Malignant Peritoneal Mesothelioma and Germline Mutation
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Yaniv Berger, MD – University of Chicago ### 915755###Oral Abstract Presenter

2:15 PM – 2:30 PM

PM10 - Cytoreductive Surgery in Selected Patients with Metastatic Gastric Cancer Treated with Systemic Chemotherapy
Location: Sebastian I 1/2

TrackPeritoneal Metastases

Favorite

Yaniv Berger, MD – University of Chicago ### 915755###Oral Abstract Presenter

3:15 PM – 5:15 PM

Career Development Workshop

3:30 PM – 3:45 PM

Building a Successful Practice
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Kiran K. Turaga, MD, MPH – University of Chicago ### 894418###Speaker#########
Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

3:45 PM – 4:00 PM

How to Manage Your Time: Emails, Appointments and More
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Jonathan S. Zager, MD – H. Lee Moffitt Cancer Center ### 917915###Speaker

4:00 PM – 4:15 PM

How to Say No
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Laura Lambert, MD – Huntsman Cancer Institute, University of Utah ### 915773###Speaker

4:15 PM – 4:30 PM

Steps for Publishing Success
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

T. Clark Gamblin, MD, MS, MBA – Medical College of Wisconsin ### 917900###Speaker

4:30 PM – 4:45 PM

Building a Network: Committees, Boards, and Influence
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

David L. Bartlett, MD – University of Pittsburgh School of Medicine ### 917897###Speaker

4:45 PM – 5:00 PM

Finding the Right Job and Creating Value: Two Perspectives
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

H. Richard Alexander, Jr., MD – Rutgers Cancer Institute ### 917895###Speaker @@@ Oliver Eng, MD – University of Chicago ### 917899###Speaker

5:00 PM – 5:15 PM

Mentor/Mentee Session
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Fabian M. Johnston, MD MHS – Johns Hopkins University ### 917904###Speaker

Sunday, February 16, 2020
7:30 AM – 9:00 AM

Peritoneal Metastases Session 3

7:30 AM – 7:45 AM

PM11 - Definition and Prediction of Early Recurrence and Mortality Following CRS HIPEC: Predicting Futility Preoperatively
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackPeritoneal Metastases

Favorite

Caroline Rieser, MD – University of Pittsburgh Medical Center ### 915790###Oral Abstract Presenter

7:45 AM – 8:00 AM

PM12 - Quality Analysis of Operative Reports and Referral Data for Appendiceal Peritoneal Carcinomatosis
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackPeritoneal Metastases

Favorite

Christopher W. Mangieri, MD – Wake Forest University Baptist Medical Center ### 915777###Oral Abstract Presenter

8:00 AM – 8:15 AM

PM13 - Treatment Variation and Long-Term Outcomes of Appendiceal Neoplasms
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackPeritoneal Metastases

Favorite

Christopher Scally, MD, MS – University of Texas MD Anderson Cancer Center ### 915792###Oral Abstract Presenter

8:15 AM – 8:30 AM

PM14 - A Multi-Institutional Analysis of Textbook Outcomes Among Patients Undergoing Cytoreductive Surgery for Peritoneal Surface Malignancies
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackPeritoneal Metastases

Favorite

Jason T. Wiseman, MD, MSPH – The Ohio State University ### 915802###Oral Abstract Presenter

9:30 AM – 10:30 AM

Peritoneal Metastases Session 4

9:30 AM – 9:45 AM

PM15 - A Novel Preoperative Risk Score to Optimize Patient Selection for Performing Concomitant Liver Resection with Cytoreductive Surgery/HIPEC
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackPeritoneal Metastases

Favorite

Rachel M. Lee, MD, MSPH – Winship Cancer Institute, Emory University ### 915774###Oral Abstract Presenter

9:45 AM – 10:00 AM

PM16 - Exosomes as a Novel Immunotherapeutic Approach for Metastatic Ovarian Cancer Treatment
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackPeritoneal Metastases

Favorite

Simone Pisano, MS – Houston Methodist Research Institute ### 915785###Oral Abstract Presenter

10:00 AM – 10:15 AM

PM17 - Mismatch Repair Deficiency is Associated with Worse Survival in Colorectal/Appendiceal Cancers with Peritoneal Metastases
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackPeritoneal Metastases

Favorite

Scott K. Sherman, MD – University of Iowa Carver College of Medicine ### 915795###Oral Abstract Presenter

10:15 AM – 10:30 AM

PM18 - Peritoneal Cell-Free Tumor DNA as a Biomarker of Disease Burden in Peritoneal Carcinomatosis
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackPeritoneal Metastases

Favorite

Katie M. Leick, MD, MS – University of Iowa ### 915775###Oral Abstract Presenter

10:30 AM – 12:00 PM

Applied Research Session 1

10:30 AM – 10:45 AM

AR1 - Expanded Mutation Profiling in Appendix Peritoneal Metastasis Has Prognostic and Therapeutic Utility When Managed with Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackApplied Research

Favorite

Chunmeng Zhang, MD – University of Nebraska Medical Center ### 915806###Oral Abstract Presenter

10:45 AM – 11:00 AM

AR2 - Establishing Novel Mutation Subtypes in Peritoneal Carcinomatosis of Appendiceal Origin
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackApplied Research

Favorite

Mary Garland-Kledzik, MD – John Wayne Cancer Institute ### 915763###Oral Abstract Presenter

11:00 AM – 11:15 AM

AR3 - Genetic Signatures Can Identify Appendiceal Cancer Patients with Poor Outcomes Who Would Less Likely Benefit From Incomplete Cytoreduction/HIPEC
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackApplied Research

Favorite

Omeed Moaven, MD – Wake Forest University ### 915779###Oral Abstract Presenter

11:15 AM – 11:30 AM

AR4 - Exosomal microRNA in Peritoneal Fluid as a Biomarker of Peritoneal Metastases from Gastric Cancer
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackApplied Research

Favorite

Joji Kitayama, MD, PhD – Jichi Medical University ### 915771###Oral Abstract Presenter

1:30 PM – 2:30 PM

Applied Research Session 2

1:30 PM – 1:45 PM

AR5 - Inhibition of Neutrophil Extracellular Traps (NETs) with Chloroquine Reduces Peritoneal Metastatic Tumor Burden
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackApplied Research

Favorite

Pavan Rao, MD – Allegheny General Hospital ### 915787###Oral Abstract Presenter

1:45 PM – 2:00 PM

AR6 - Intraperitoneal CMP-001, A Novel Immunotherapy for Treating Peritoneal Carcinomatosis of Gastrointestinal and Pancreaticobiliary Cancers
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackApplied Research

Favorite

Carlos HF Chan, MD, PhD – University of Iowa Hospitals and Clinics ### 915756###Oral Abstract Presenter

2:00 PM – 2:15 PM

AR7 - Colon and Appendiceal Cancer Organoids for Comparison of Ex-Vivo Efficacy of Mitomycin C and Oxaliplatin Perfusion Regimens
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackApplied Research

Favorite

Steven Forsythe, MSc – Wake Forest University ### 915761###Oral Abstract Presenter

2:15 PM – 2:30 PM

AR8 - PD-L1 Expression is Altered in Malignant Peritoneal Mesothelioma Patients after Chemotherapy and HIPEC
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackApplied Research

Favorite

Lai Xue, MD – University of Chicago ### 915804###Oral Abstract Presenter

3:00 PM – 5:00 PM

Bringing the Heat: The Challenges and Opportunities of Starting a HIPEC Program

3:05 PM – 3:15 PM

Starting a HIPEC Program in an Academic Center
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Charles A. Staley, MD – Emory ### 915797###Speaker

3:15 PM – 3:25 PM

Starting a HIPEC Program in the Shadow of a Large HIPEC Program
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Colette R. Pameijer, MD – Penn State Cancer Institute ### 915784###Speaker

3:25 PM – 3:35 PM

Starting a HIPEC Program in the Community or Private Practice Setting
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Sharmila Roy Chowdhury, MD – Southwest Cancer Surgery ### 917911###Speaker

3:35 PM – 3:45 PM

Finding Allies for your HIPEC Program
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Laura Lambert, MD – Huntsman Cancer Institute, University of Utah ### 915773###Speaker

3:45 PM – 3:55 PM

Billing for HIPEC
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Kiran K. Turaga, MD, MPH – University of Chicago ### 894418###Speaker#########
Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

3:55 PM – 4:05 PM

Pediatric HIPEC
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Andrea HAYES-JORDAN, MD – UNC Chapel Hill ### 917902###Speaker

4:05 PM – 4:15 PM

Developing Prospective Databases and Collaborations
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackCross Disciplinary

Favorite

Shishir K. Maithel, MD – Emory ### 917909###Speaker

Monday, February 17, 2020
7:15 AM – 8:45 AM

Melanoma Session 1

7:15 AM – 7:30 AM

M1 - Current Adjuvant Therapy Use in the Setting of Sentinel Node Positivity for Melanoma
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackMelanoma

Favorite

Norma E. Farrow, MD – Duke University ### 915760###Oral Abstract Presenter

7:30 AM – 7:45 AM

M2 - An Immune Tolerant Sentinel Node Microenvironment Predicts Recurrence in Melanoma
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackMelanoma

Favorite

Norma E. Farrow, MD – Duke University ### 915760###Oral Abstract Presenter

7:45 AM – 8:00 AM

M3 - Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: A Multi-Institutional Experience
Location: Sebastian I 1/2

Speaker: Kiran K. Turaga, MD, MPH – University of Chicago

TrackMelanoma

Favorite

James Sun, MD – Moffitt Cancer Center ### 915799###Oral Abstract Presenter

8:00 AM – 8:15 AM

M4 - International Multi-Center Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients
Location: Sebastian I 1/2

Oral Abstract Presenter: Hidde M. Kroon, MD, PhD – Royal Adelaide Hospital

Oral Abstract Presenter: Michael J. Carr, MD, MS – Moffitt Cancer Center

TrackMelanoma

Favorite

Hidde M. Kroon, MD, PhD – Royal Adelaide Hospital ### 915772###Oral Abstract Presenter#########
Oral Abstract Presenter: Hidde M. Kroon, MD, PhD – Royal Adelaide Hospital
@@@ Michael J. Carr, MD, MS – Moffitt Cancer Center ### 918093###Oral Abstract Presenter#########
Oral Abstract Presenter: Michael J. Carr, MD, MS – Moffitt Cancer Center

8:15 AM – 8:30 AM

M5 - International Comparison of Oncologic Outcomes after Isolated Limb Infusion (ILI) for Advanced Melanoma
Location: Sebastian I 1/2

Oral Abstract Presenter: Michael J. Carr, MD, MS – Moffitt Cancer Center

TrackMelanoma

Favorite

Michael J. Carr, MD, MS – Moffitt Cancer Center ### 918093###Oral Abstract Presenter#########
Oral Abstract Presenter: Michael J. Carr, MD, MS – Moffitt Cancer Center

8:30 AM – 8:45 AM

M6 - Isolated Limb Perfusion as an Effective Treatment Modality for Locally Advanced Kaposi Sarcoma of the Extremities
Location: Sebastian I 1/2

Oral Abstract Presenter: Michael J. Carr, MD, MS – Moffitt Cancer Center

TrackMelanoma

Favorite

Winan van Houdt, MD, PhD – Netherlands Cancer Institute ### 915789###Oral Abstract Presenter